SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer (C95084)

NCT00002960 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Fallopian Tube Cancer
Metastatic Cancer
Ovarian Cancer
Primary Peritoneal Cavity Cancer

Interventions

BIOLOGICAL: recombinant adenovirus-p53 SCH-58500

Sponsor

Merck Sharp & Dohme LLC